期刊文献+

慢性阻塞性肺疾病治疗药物进展 被引量:2

Progress in treatment of chronic obstructive pulmonary disease
下载PDF
导出
摘要 慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)是一种具有气流阻塞特征的慢性支气管炎以及肺气肿,可逐渐发展为肺心病以及呼吸衰竭的慢性疾病。COPD的发病机制复杂,发病率及致死率较高,其主要临床症状表现为慢性咳嗽、咳痰、气短或呼吸困难。目前治疗COPD的药物有糖皮质激素、茶碱类药物、抗胆碱药物、β2受体激动剂等,均能缓解COPD的临床症状,控制病情反复发作,对提高患者生活质量具有重要意义。 Chronic obstructive pulmonary disease(chronic obstructive pulmonary disease,COPD)is a clinical chronic bronchitis and emphysema characterized by airflow obstruction,which can gradually develop into chronic pulmonary heart disease and respiratory failure.The incidence and mortality of COPD are increasing year by year in China,especially in elderly patients.The choice of drugs for COPD has always been the focus of attention of the community.Common drugs for COPD include theophylline drugs,anticholinergics,beta 2 receptor agonists,etc.These drugs can alleviate the clinical symptoms of COPD,prevent the recurrence of the disease,and improve the quality of life of patients.They are of great significance in clinical application.
作者 黄少虎 HUANG Shao-hu(Baise maternal and child health hospital,Baise,Guangxi,533000,China)
出处 《蛇志》 2020年第1期103-105,共3页 Journal of Snake
关键词 慢性阻塞性肺疾病 治疗药物 支气管扩张剂 抗炎 Bronchodilators Chronic obstructive pulmonary disease Respiratory failure Chronic diseases
  • 相关文献

参考文献19

二级参考文献173

共引文献186

同被引文献19

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部